 TORONTO--BUSINESS WIRE--Cybin Inc. NEO:CYBN NYSE American:CYBN Cybin or the Company, a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM is pleased to announce that Doug Drysdale, Cybins Chief Executive Officer, will present at the KCSA Psychedelics Virtual Investor Conference at 11:00 a.m. ET on Thursday, April 28, 2022. This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. To participate 